Literature DB >> 11413093

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

J Hirsh, S S Anand, J L Halperin, V Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11413093     DOI： 10.1161/01.cir.103.24.2994

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  105 in total

Review 1.  Direct thrombin inhibitors in cardiovascular disease.

Authors:  Kyle A Arsenault; Jack Hirsh; Richard P Whitlock; John W Eikelboom
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

2.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

3.  Heparin resistance in acute coronary syndromes.

Authors:  Jonathan D Rich; John M Maraganore; Edward Young; Rosa-Maria Lidon; Burt Adelman; Paul Bourdon; Supoat Charenkavanich; Jack Hirsh; Pierre Theroux; Christopher P Cannon
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

Review 4.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

5.  Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.

Authors:  Eric Pautas; Isabelle Gouin; Oliver Bellot; Jean-Paul Andreux; Virginie Siguret
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.

Authors:  Duaa Alsulaiman; Katelyn Sylvester; Craig Stevens; Danielle Carter
Journal:  Hosp Pharm       Date:  2016-09

7.  A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin.

Authors:  Junxin Wang; Fang Chen; Santiago J Arconada-Alvarez; James Hartanto; Li-Peng Yap; Ryan Park; Fang Wang; Ivetta Vorobyova; Grant Dagliyan; Peter S Conti; Jesse V Jokerst
Journal:  Nano Lett       Date:  2016-09-28       Impact factor: 11.189

8.  Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.

Authors:  Marzenna Zielinska; Krzysztof Kaczmarek
Journal:  J Thromb Thrombolysis       Date:  2008-05-04       Impact factor: 2.300

9.  On designing non-saccharide, allosteric activators of antithrombin.

Authors:  Arjun Raghuraman; Aiye Liang; Chandravel Krishnasamy; Trish Lauck; Gunnar T Gunnarsson; Umesh R Desai
Journal:  Eur J Med Chem       Date:  2008-10-09       Impact factor: 6.514

10.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.